The new plan has a troubling feature that could cause student loan payments to arbitrarily jump after borrowers experience a small pay raise.
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results